Table 1.

Patients characteristics

No. of patients	27
Median age [range], years	61.4 [47.6 - 74.1]
Gender
Male	15 (55.6%)
Female	12 (44.4%)
ECOG performance status score
0	5 (18.5%)
1	7 (25.9%)
2	9 (33.3%)
3	3 (11.1%)
Unknown	3 (11.1%)
First line chemotherapy
FOLFIRI.3 alternating with Gemcitabine	7 (25.9%)
Gemcitabine	20 (74.1%)
Pancreatic tumor location
Head	14 (51.8%)
Body	6 (22.2%)
Tail	6 (22.2%)
Multicentric	1 (3.7%)
Metastatic sites
Liver	20 (74.1%)
Peritoneum	8 (29.6%)
Lung	6 (22.2%)
Distant lymph nodes	2 (7.4%)
No. of metastatic sites involved
1	19 (70.4%)
2	7 (25.9%)
≥ 3	1 (3.7%)
Baseline CA 19–9 level
≤ 37 UI/ml*	2 (7.4%)
> 37 UI/ml	19 (70.4%)
Unknown	6 (22.2%)
No. of cycle
Mean	6
Median [range]	4 [1–28]

Abbrevations:ECOG Eastern Cooperative Oncology Group;

*upper limit of normal value.